BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 29459277)

  • 21. Inhibition of cell proliferation by quindoline derivative (SYUIQ-05) through its preferential interaction with c-myc promoter G-quadruplex.
    Ou TM; Lin J; Lu YJ; Hou JQ; Tan JH; Chen SH; Li Z; Li YP; Li D; Gu LQ; Huang ZS
    J Med Chem; 2011 Aug; 54(16):5671-9. PubMed ID: 21774525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of a New Four-Leaf Clover-Like Ligand as a Potent c-MYC Transcription Inhibitor Specifically Targeting the Promoter G-Quadruplex.
    Hu MH; Wang YQ; Yu ZY; Hu LN; Ou TM; Chen SB; Huang ZS; Tan JH
    J Med Chem; 2018 Mar; 61(6):2447-2459. PubMed ID: 29474069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Looking for efficient G-quadruplex ligands: evidence for selective stabilizing properties and telomere damage by drug-like molecules.
    Pagano B; Amato J; Iaccarino N; Cingolani C; Zizza P; Biroccio A; Novellino E; Randazzo A
    ChemMedChem; 2015 Apr; 10(4):640-9. PubMed ID: 25694275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced or diminished stabilization of the telomere G-quadruplex and inhibition of telomerase by small chemical ligands under molecular crowding condition.
    Chen Z; Zheng KW; Hao YH; Tan Z
    J Am Chem Soc; 2009 Aug; 131(30):10430-8. PubMed ID: 19588966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Telomeric G-Quadruplex Selective Fluoro-Isoquinolines Induce Apoptosis in Cancer Cells.
    Maiti S; Saha P; Das T; Bessi I; Schwalbe H; Dash J
    Bioconjug Chem; 2018 Apr; 29(4):1141-1154. PubMed ID: 29433312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific targeting of telomeric multimeric G-quadruplexes by a new triaryl-substituted imidazole.
    Hu MH; Chen SB; Wang B; Ou TM; Gu LQ; Tan JH; Huang ZS
    Nucleic Acids Res; 2017 Feb; 45(4):1606-1618. PubMed ID: 27923993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fe
    Malina J; Kostrhunova H; Scott P; Brabec V
    Chemistry; 2021 Aug; 27(45):11682-11692. PubMed ID: 34048082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting promoter G-quadruplex DNAs by indenopyrimidine-based ligands.
    Diveshkumar KV; Sakrikar S; Harikrishna S; Dhamodharan V; Pradeepkumar PI
    ChemMedChem; 2014 Dec; 9(12):2754-65. PubMed ID: 25359695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chelerythrine down regulates expression of VEGFA, BCL2 and KRAS by arresting G-Quadruplex structures at their promoter regions.
    Jana J; Mondal S; Bhattacharjee P; Sengupta P; Roychowdhury T; Saha P; Kundu P; Chatterjee S
    Sci Rep; 2017 Jan; 7():40706. PubMed ID: 28102286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific Stabilization of c-MYC and c-KIT G-Quadruplex DNA Structures by Indolylmethyleneindanone Scaffolds.
    Diveshkumar KV; Sakrikar S; Rosu F; Harikrishna S; Gabelica V; Pradeepkumar PI
    Biochemistry; 2016 Jun; 55(25):3571-85. PubMed ID: 27226253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
    Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN
    J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural insights into G-quadruplexes: towards new anticancer drugs.
    Yang D; Okamoto K
    Future Med Chem; 2010 Apr; 2(4):619-46. PubMed ID: 20563318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbazole Derivatives' Binding to c-KIT G-Quadruplex DNA.
    Głuszyńska A; Juskowiak B; Kuta-Siejkowska M; Hoffmann M; Haider S
    Molecules; 2018 May; 23(5):. PubMed ID: 29747481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective recognition of oncogene promoter G-quadruplexes by Mg2+.
    Yan YY; Lin J; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
    Biochem Biophys Res Commun; 2010 Nov; 402(4):614-8. PubMed ID: 20971074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenanthroline polyazamacrocycles as G-quadruplex DNA binders.
    Carvalho J; Quintela T; Gueddouda NM; Bourdoncle A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
    Org Biomol Chem; 2018 Apr; 16(15):2776-2786. PubMed ID: 29611599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of telomere G-quadruplex stabilization to the inhibition of telomerase-mediated telomere extension by chemical ligands.
    Chen CY; Wang Q; Liu JQ; Hao YH; Tan Z
    J Am Chem Soc; 2011 Sep; 133(38):15036-44. PubMed ID: 21846102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of the first dual G-triplex/G-quadruplex stabilizing compound: a new opportunity in the targeting of G-rich DNA structures?
    Amato J; Pagano A; Cosconati S; Amendola G; Fotticchia I; Iaccarino N; Marinello J; De Magis A; Capranico G; Novellino E; Pagano B; Randazzo A
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1271-1280. PubMed ID: 27836755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Energetics of ligand binding to G-quadruplexes.
    Giancola C; Pagano B
    Top Curr Chem; 2013; 330():211-42. PubMed ID: 22851158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nemorubicin and doxorubicin bind the G-quadruplex sequences of the human telomeres and of the c-MYC promoter element Pu22.
    Scaglioni L; Mondelli R; Artali R; Sirtori FR; Mazzini S
    Biochim Biophys Acta; 2016 Jun; 1860(6):1129-38. PubMed ID: 26922833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homogeneous selecting of a quadruplex-binding ligand-based gold nanoparticle fluorescence resonance energy transfer assay.
    Jin Y; Li H; Bai J
    Anal Chem; 2009 Jul; 81(14):5709-15. PubMed ID: 19527045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.